FDA Approves Once-Monthly Single Injection of Omvoh for Ulcerative Colitis
Eli Lilly and Company announced on October 27, 2025, that the U.S. Food and Drug Administration (FDA) approved a simplified, single-injection, once-monthly maintenance regimen of Omvoh (mirikizumab-mrzk) for adults with […]
FDA Approves Once-Monthly Single Injection of Omvoh for Ulcerative Colitis Read More »
